TL;DR
This study reveals that lysine crotonylation (KCr), a post-translational modification, plays a crucial role in maintaining mitochondrial health and combating inflammation in ulcerative colitis (UC). By enhancing KCr, particularly on the enzyme citrate synthase (CS), the researchers found they could restore mitochondrial function, reduce oxidative stress, and suppress inflammatory pathways, suggesting KCr modulation as a novel therapeutic avenue for UC.
What Problem Does This Paper Address?
Ulcerative colitis (UC) is a chronic and debilitating inflammatory bowel disease with limited effective treatments. While its pathogenesis is complex, involving immune dysregulation, gut microbiota imbalances, and genetic factors, the precise molecular mechanisms underlying its progression are not fully understood. Specifically, the role of post-translational modifications (PTMs) in UC, beyond well-studied ones like acetylation, remains an area ripe for exploration. This paper focuses on lysine crotonylation (KCr), a relatively new PTM, and investigates its potential involvement in UC by examining its impact on mitochondrial function and inflammatory responses. The authors aim to uncover the pathophysiological relevance of KCr in UC and identify potential therapeutic targets.
Methods
The researchers employed a multi-pronged approach:
- DSS-induced UC Mouse Model: They established a standard model of UC in mice using dextran sulfate sodium (DSS) to mimic the disease's inflammatory and structural changes.
- PTM Proteomics: This was a key technique to globally identify and quantify changes in lysine crotonylation (and other acylations like succinylation, malonylation, and lactylation) in the colon tissue of UC mice compared to controls. This allowed them to pinpoint proteins and specific lysine residues affected by KCr.
- Western Blotting: Used to validate the proteomic findings and assess the protein levels of key players in mitophagy (PINK1, PARKIN, LC3, P62) and inflammation (NLRP3, IL-1β, TNF-α), as well as apoptosis markers (BAX, BAD, BAK, BCL2).
- Functional Assays:
- TCA Cycle Analysis: Measured the levels of metabolites in the tricarboxylic acid (TCA) cycle to assess the functional impact of KCr on these enzymes.
- Oxidative Stress Markers: Assessed levels of MDA, SOD, and GSH to quantify oxidative stress.
- Cell Viability Assays (CCK8): Evaluated the effect of treatments on cell health.
- qPCR: Quantified mRNA expression of key genes involved in inflammation and autophagy.
- Transmission Electron Microscopy (TEM): Visualized the ultrastructure of mitochondria to assess damage and repair.
- In Vitro Studies: Utilized the NCM460 human intestinal epithelial cell line, induced with lipopolysaccharide (LPS), to further investigate the effects of KCr and specific protein modifications.
- Site-Specific Mutagenesis: Introduced mutations in the citrate synthase (CS) gene, specifically at the K375 residue (a key crotonylation site identified in proteomics), to create non-crotonylatable (K375R) and crotonylation-mimicking (K375Q) variants. This allowed for a precise understanding of the role of K375 crotonylation.
- Pharmacological Inhibition: Used mitophagy inhibitors (chloroquine - CQ, Mdivi-1) to dissect the role of mitophagy in KCr-mediated effects.
Datasets
Not explicitly detailed as "datasets" in the traditional machine learning sense. The primary "data" comes from:
- Colon tissue samples from control and DSS-induced UC mice.
- Serum samples from these mice.
- NCM460 cell line cultures treated with LPS and/or NaCr.
The study generated quantitative proteomics data on KCr modifications and protein expression levels, as well as various biochemical and molecular assay results.
Key Insights and Ideas
- KCr is Dysregulated in UC: The study clearly demonstrates that lysine crotonylation levels are significantly altered in the colon tissue of UC mice, with a notable decrease in key TCA cycle enzymes. This suggests KCr is not just a bystander but actively involved in the disease process.
- Mitochondria and TCA Cycle Link: The proteomic analysis revealed that differentially crotonylated proteins were heavily enriched in the mitochondria and associated with the TCA cycle. This highlights a critical connection between KCr, mitochondrial function, and UC.
- Citrate Synthase (CS) as a Key Player: Citrate synthase (CS), a crucial rate-limiting enzyme in the TCA cycle, emerged as a prominent target of KCr. Reduced KCr on CS in UC mice correlated with impaired citrate production, underscoring the functional importance of this modification.
- KCr as a Protective Modulator: Exogenously increasing KCr levels using sodium crotonate (NaCr) in UC models (both in vivo and in vitro) significantly ameliorated disease symptoms, reduced inflammation, and improved mitochondrial morphology.
- Mitophagy is the Mechanism: The study strongly suggests that KCr's protective effects are mediated through the induction of mitophagy – the selective degradation of damaged mitochondria. This process is activated via the PINK1/PARKIN pathway.
- NLRP3 Inflammasome Inhibition: A critical finding is that KCr-induced mitophagy effectively suppresses the activation of the NLRP3 inflammasome, a key driver of inflammation in UC. This inhibition is dependent on the mitophagy process.
- K375 on CS is Crucial: By using site-specific mutagenesis, the researchers pinpointed the K375 residue on CS as a critical crotonylation site. Crotonylation at this specific site is essential for inducing mitophagy and suppressing NLRP3 inflammasome activation.
Key Results
- UC Model: DSS treatment led to characteristic UC symptoms including shorter colons, weight loss, and increased DAI scores.
- Proteomics: Identified significant alterations in KCr levels, with enrichment in mitochondrial proteins involved in the TCA cycle.
- NaCr Treatment: Significantly improved body weight, reduced DAI scores, increased colon length, and restored colon morphology in DSS-induced UC mice. It also reduced pro-inflammatory cytokines (IFN-γ, TNF-α, IL-6, etc.) and increased anti-inflammatory cytokines (IL-4, IL-10).
- Mitochondrial Health: NaCr treatment improved mitochondrial morphology, reduced oxidative stress markers (decreased MDA, increased SOD and GSH), and attenuated apoptosis.
- Mitophagy Induction: Increased KCr levels (via NaCr) led to increased LC3II and P62 levels, indicating enhanced autophagy, and upregulated PINK1 and PARKIN expression, confirming mitophagy activation.
- NLRP3 Inhibition: NaCr treatment reduced NLRP3 expression, and this effect was reversed by mitophagy inhibitors (CQ, Mdivi-1), confirming mitophagy's role in NLRP3 suppression.
- CS K375 Site: Mutation of CS K375 to R (non-crotonylatable) impaired mitophagy and NLRP3 inhibition, while mutation to Q (mimicking crotonylation) enhanced these effects.
Limitations and Future Work
- Generalizability of NaCr: While NaCr showed promising results, it acts as a general crotonylation inducer. The study acknowledges that its beneficial effects might involve other proteins beyond CS, necessitating further investigation into the broader impact of KCr.
- Specific Regulatory Relationship: The precise regulatory relationship between CS crotonylation and CS expression itself remains unclear and warrants further exploration.
- Mechanism of Interaction: The detailed molecular mechanisms underlying the interaction between crotonylation and mitophagy need to be further elucidated.
- Therapeutic Potential: The study suggests NaCr as a potential therapeutic option, but further preclinical and clinical studies would be required to confirm its safety and efficacy in humans.
- Drug Development: The authors propose that drugs targeting crotonylation modifications could be a promising avenue for clinical drug development in UC management.
Summary updated